Review Article

Phytochemicals in the Treatment of Alzheimer’s Disease: A Systematic Review

Author(s): Grazia D'Onofrio*, Daniele Sancarlo, Qingwei Ruan, Zhuowei Yu, Francesco Panza, Antonio Daniele, Antonio Greco and Davide Seripa

Volume 18, Issue 13, 2017

Page: [1487 - 1498] Pages: 12

DOI: 10.2174/1389450117666161102121553

Price: $65

Abstract

Background: Alzheimer's disease (AD) is the most widespread age-related neurodegenerative disease. Recently, a growing body of evidence suggested the phytochemical use to slow down AD onset and progression.

Objective: To review the phytochemical role potentially involved in AD treatment.

Method: A systematic review from existing literature on phytochemicals used in the treatment of AD patients was conducted. Selection criteria included: 1) age≥60 years; 2) AD diagnosis in agreement with the criteria of National Institute on Aging-Alzheimer's Association (NIAAA), and 3) suitable measures to asses cognitive, functional and clinical status.

Results: Ninety-seven articles were involved in the present study. Several phytochemicals seem to slow down AD onset, delay disease progression and let recovery through targeting multiple pathological causes by anti-cholinergic, antioxidant and anti-inflammatory features.

Conclusion: Deeper knowledge on phytochemicals and their specific molecular targets is essential to guarantee safe use of these compounds as an option for AD treatment.

Keywords: Phytochemicals, Alzheimer's disease, antioxidant properties, anti-inflammatory activities, acetilcholinesterase inhibitors, AChEIs.

Graphical Abstract

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy